3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
6
Gastro-enteropancreatic neuroendocrine tumor
2
Carcinoid Tumor
2
Serotonin Syndrome
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Neuroendocrine Tumour With Carcinoid Symptoms
1
Neuroendocrine Tumors in Lung
1
Intestinal Obstruction
1
Flushing
1
Endocrine Tumors
1
Diarrhea
1
Carcinoma
1
Adenoma, Islet Cell
1
Acromegaly
1
Interventions
lanreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neuroendocrine Tumors in Lung
×
lanreotide
×
Clear all
NCT02683941
2022-07-06
SPINET
Ipsen
Phase 3
Terminated
77 enrolled
20 charts